How Medicines Law & Policy
is Aiding the Covid-19 Response
is Aiding the Covid-19 Response
European Union Review of Pharmaceutical Incentives:
Suggestions for Change
A new briefing paper series from Medicines Law & Policy
Suggestions for Change
A new briefing paper series from Medicines Law & Policy
EU Review of Pharmaceutical
Incentives: Suggestions for Change
Incentives: Suggestions for Change
Medicines Law & Policy creates tools countries and others looking to increase access to medicines can use to overcome patent barriers when needed.
Medicines Law & Policy maintains a database
documenting use of TRIPS Flexibilities
to increase access to medicines worldwide.
documenting use of TRIPS Flexibilities
to increase access to medicines worldwide.
Medicines Law & Policy releases analysis,
policy recommendations and tools to aid practitioners
working on universal access to medicines.
policy recommendations and tools to aid practitioners
working on universal access to medicines.
Latest insight from Medicines Law & Policy
Vaccine knowledge needs to be a global public good: Remarks to the World Trade...
Ellen ‘t Hoen, Medicines Law & Policy, at the World Trade Organization-World Health Organization High-Level Dialogue on Expanding COVID-19 Vaccine Manufacturing to Promote Equitable...
Advanced Purchase Agreements for Covid-19 Vaccines: Do they ensure Global Public Good?
Advanced Purchase Agreements (APAs) were part of a strategy to provide upfront financing for Covid-19 vaccines and to accelerate their development and availability. Since...
Covid shows the world it needs new rules to deal with pandemics
The World Health Assembly, the World Health Organization (WHO)'s annual decision-making meeting, begins next week and will run from 24 May - 1 June....
Independent Panel for Pandemic Preparedness and Response: Uneven access to vaccination is pre-eminent problem
The Independent Panel for Pandemic Preparedness and Response (IPPPR) today released its findings in a report titled “Covid-19: Make it the last pandemic,” laying...
US supports the Covid-19 TRIPS Waiver for vaccines; Now, technology sharing must become a...
The United States Government announced on 5 May a bold move to drop its opposition to the proposal to waive intellectual property rights related...
BMJ Commentary: Overriding drug and medical technology patents for pandemic recovery: a legitimate move...
Interest in the use of compulsory licensing is making a comeback in high-income countries in response to concerns about access to Covid-19 vaccines and...
This work is licensed under